Lecture 27 - Ovarian Cancer Flashcards

1
Q

What are the four stages of ovarian cancer?

A

Before ovarian cancer: Healthy ovaries
Stage I: Cancer is confined to one or both of the ovaries
Stage II: Cancer spreads within the pelvic
Stage III: Average stage of diagnosis when cancer spreads to other body parts within the abdomen
Stage IV: Cancer spreads beyond the abdomen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Is ovarian cancer the same disease?

A

Molecular and genetic analysis has determined that cancer is not a single disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the 5 major histotypes in ovarian cancer (defined by both histology and molecular profiles)?

A
  • High-grade serous carcinoma (>80%)
  • Low-grade serous cacinoma
  • Endometrioid
  • Mucinous
  • Clear-cell carcinoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

In the past 20 years, how have the survival rates of ovarian cancer changed?

A
  • There has been no change, meaning survival rates have not improved nor have they decreased
  • The 5 year survival rate is between 20-40% depending on the histology of cancer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Why is it important to learn and identify the different histotypes?

A
  • they all have different metabolic traits

- want to accurately diagnose to provide the proper treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the characteristics of Endometrioid?

A
  • Have tubular glands
  • There are solid and cystic regions
  • Has an enlarged nuclei and other abnormal features
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the characteristics of Mucinous?

A
  • It has an expansive pattern of invasion
  • There are smooth surfaces
  • Multi-lobular (several lobes)
  • Has a mucin appearance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the characteristics of Low Grade Serous Carcinoma?

A
  • Glandular lined by bland cells
  • Has little mitotic activity
  • Has normal nuclear morphology (no enlarged nuclei)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the characteristics of Clear Cell Ovarian Carcinoma?

A
  • Contains microcystic masses with solid nodules (feels nodule-like)
  • Has regions of clear cell-like appearance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the characteristics of High-Grade Serous Ovarian Carcinoma?

A
  • Has a papillary/micropapillary (nipple like structure) form
  • Contains slit-like spaces between cells
  • Is glandular and solid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the Type I tumours in ovarian cancer?

A
  • Endometrioid
  • Mucinous
  • Clear Cell
  • Low grade Serous
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the characteristics of Type I tumours?

A
  • Low grade
  • Slow growing
  • Encompasses all histologies
  • Likely evolve through a step-wise progress from borderline tumours
  • Usually chomosomally stable (not picking up mutations frequently)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are Type II Tumours in ovarian cancers?

A
  • Endometrioid
  • Carcinosarcoma
  • Clear Cell
  • High-grade serous carcinoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the characteristics of Type II Tumours?

A
  • High-grade
  • Evolve rapidly
  • Includes: high-grade serous carcinoma, high-grade endometrioid carcinoma, carcinosarcoma, undifferentiated carcinoma and some clear cell carcinomas
  • No recognizable precursors in the ovary
  • Widespread DNA copy number changes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Where are the two locations people have hypothesized ovarian cancer arises from?

A
  • The epithelial cells that line the ovary

- Somewhere on the Fallopian tubes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Explain how a normal or mutant stem cell precursor can become ovarian cancer.

A
  • The mutant stem cell precursor becomes entrapped during ovulation when the surface endothelium was remodeled
  • Envagination occurs and results in a cortical inclusion cyst: aberrant niche (which could result in Type II tumours)
  • The cyst then becomes a Mullerian metaplasia, if it had not differentiated into a Type II tumour cell, before undergoing malignant transformation
  • results in Type I tumours
17
Q

Explain how ovarian cancer arises from the Fallopian tubes.

A
  • During ovulation, a rupture in the ovary and some of the cells from the fimbriae enter it
  • A normal or mutant stem cell precursor undergoes a p53 signature mutation
  • The mutations the lead to STIC which undergoes ectropic implantation
  • An aberrant niche forms before undergoing a malignant transformation to become a High-grade serous
18
Q

What stands out when looking at the molecular alterations in the various histotypes of ovarian cancer?

A

The histotypes all have different molecular feature combinations
eg., High-grade serous carcinoma -> TP53, BRCA1 and P13KCA

19
Q

What was the first line of treatment 30 years ago?

A
  • Debulking surgery - remove tumour
  • Chemotherapy - Platinum
  • Radiation - Clear cell ovarian cancer
20
Q

What was the second line treatment (recurrent disease) 30 years ago?

A
  • Chemotherapy - Platinum

- Repeat

21
Q

What is the first line of treatment now?

A
  • Neoadjuvant chemotherapy (before surgery)
  • Debulking surgery - remove tumour
  • Hysterectomy - Removal of uterus
  • Unilateral salpingo-oophorectomy - removal of one ovary and Fallopian tube
  • Bilateral salpingo-oophorectomy - removal of both ovaries and Fallopian tubes
22
Q

What is the modern day Second line treatment (recurrent sensitive or resistant)?

A

Recurrent sensitive
- Chemotherapy - carboplatin, paclitaxel, doxorubicin and gemcitabine
Recurrent resistant
- Chemotherapy - non-platinum single agent, gemcitabine, doxorubicin and paclitaxel

23
Q

What is the modern day Third Line treatment (recurrent resistant/sensitive)?

A
  • Chemotherapy

- PARP inhibitor (BRCA1 mutation carriers - once approved)

24
Q

Why are PI3K and Akt signalling important in ovarian cancer?

A
  • PI3K activates AKT downstream
  • Akt is the central regulator of signals from the cell surface that leads to proliferation, survival and cell growth
  • Akt inhibits the activation of mTOR
  • these pathways represent novel targets for the treatment of ovarian cancer and better therapies